Drug Review Results & Process

Drug Review Process

Before being considered for inclusion as benefits under the PharmaCare program, all drugs must be reviewed.

For information on the drug review process in Canada and in British Columbia, please refer to our information sheet.

Drug Review Results Information

This section of the website provides information on:

• all drugs reviewed by the national Common Drug Review (CDR) and subsequently submitted to PharmaCare for consideration;
• all drug reviews completed by PharmaCare on or after January 1, 2005;
• basic information on the brand name drugs currently under review by PharmaCare and the CDR; and
• explanations of some PharmaCare drug coverage decisions. (Additional drug coverage decision information is added regularly.)

Information on the review of generic drugs is not included as these reviews are usually completed within 6 to 8 weeks of receipt of a manufacturer's submission.

For information on the benefit status of drugs not included in the search data, please contact our HelpDesk